CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis.
Saved in:
| Title: | CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis. |
|---|---|
| Authors: | Lerner EC; Duke University School of Medicine, Durham, NC, USA.; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Woroniecka KI; Department of Pathology, Duke University Medical Center, Durham, NC, USA., D'Anniballe VM; Duke University School of Medicine, Durham, NC, USA., Wilkinson DS; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Mohan AA; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Lorrey SJ; Department of Immunology, Duke University Medical Center, Durham, NC, USA., Waibl-Polania J; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Wachsmuth LP; Duke University School of Medicine, Durham, NC, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Miggelbrink AM; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Jackson JD; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Cui X; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Raj JA; Duke University School of Medicine, Durham, NC, USA., Tomaszewski WH; Department of Immunology, Duke University Medical Center, Durham, NC, USA., Cook SL; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Sampson JH; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Patel AP; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Center for Advanced Genomic Technologies, Duke University, Durham, NC, USA., Khasraw M; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA., Gunn MD; Department of Immunology, Duke University Medical Center, Durham, NC, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Fecci PE; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu. |
| Source: | Nature cancer [Nat Cancer] 2023 Sep; Vol. 4 (9), pp. 1258-1272. Date of Electronic Publication: 2023 Aug 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37537301 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CD8<superscript>+</superscript> T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lerner+EC%22">Lerner EC</searchLink>; Duke University School of Medicine, Durham, NC, USA.; Department of Biomedical Engineering, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Woroniecka+KI%22">Woroniecka KI</searchLink>; Department of Pathology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22D'Anniballe+VM%22">D'Anniballe VM</searchLink>; Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Wilkinson+DS%22">Wilkinson DS</searchLink>; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Mohan+AA%22">Mohan AA</searchLink>; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lorrey+SJ%22">Lorrey SJ</searchLink>; Department of Immunology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Waibl-Polania+J%22">Waibl-Polania J</searchLink>; Department of Pathology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Wachsmuth+LP%22">Wachsmuth LP</searchLink>; Duke University School of Medicine, Durham, NC, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Miggelbrink+AM%22">Miggelbrink AM</searchLink>; Department of Pathology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Jackson+JD%22">Jackson JD</searchLink>; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Cui+X%22">Cui X</searchLink>; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Raj+JA%22">Raj JA</searchLink>; Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Tomaszewski+WH%22">Tomaszewski WH</searchLink>; Department of Immunology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Cook+SL%22">Cook SL</searchLink>; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Sampson+JH%22">Sampson JH</searchLink>; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Patel+AP%22">Patel AP</searchLink>; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Center for Advanced Genomic Technologies, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Khasraw+M%22">Khasraw M</searchLink>; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gunn+MD%22">Gunn MD</searchLink>; Department of Immunology, Duke University Medical Center, Durham, NC, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Fecci+PE%22">Fecci PE</searchLink>; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2023 Sep; Vol. 4 (9), pp. 1258-1272. <i>Date of Electronic Publication: </i>2023 Aug 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37537301 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s43018-023-00600-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1258 Titles: – TitleFull: CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lerner EC – PersonEntity: Name: NameFull: Woroniecka KI – PersonEntity: Name: NameFull: D'Anniballe VM – PersonEntity: Name: NameFull: Wilkinson DS – PersonEntity: Name: NameFull: Mohan AA – PersonEntity: Name: NameFull: Lorrey SJ – PersonEntity: Name: NameFull: Waibl-Polania J – PersonEntity: Name: NameFull: Wachsmuth LP – PersonEntity: Name: NameFull: Miggelbrink AM – PersonEntity: Name: NameFull: Jackson JD – PersonEntity: Name: NameFull: Cui X – PersonEntity: Name: NameFull: Raj JA – PersonEntity: Name: NameFull: Tomaszewski WH – PersonEntity: Name: NameFull: Cook SL – PersonEntity: Name: NameFull: Sampson JH – PersonEntity: Name: NameFull: Patel AP – PersonEntity: Name: NameFull: Khasraw M – PersonEntity: Name: NameFull: Gunn MD – PersonEntity: Name: NameFull: Fecci PE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2662-1347 Numbering: – Type: volume Value: 4 – Type: issue Value: 9 Titles: – TitleFull: Nature cancer Type: main |
| ResultId | 1 |